Category: <span>Cancer / Oncology</span>

Genelux announces promising data from two phase I trials of GL-ONC1 in head and neck cancer and mesothelioma

Genelux Corporation, a clinical-stage biopharmaceutical company focused on the development of vaccinia virus for oncolytic immunotherapy, today announced that data from two Phase I trials…

Genelux announces promising data from two phase I trials of GL-ONC1 in head and neck cancer and mesothelioma

Genelux Corporation, a clinical-stage biopharmaceutical company focused on the development of vaccinia virus for oncolytic immunotherapy, today announced that data from two Phase I trials…

Advanced abdominal cancer: 20 years of data shows treatment technique improvement

Meaningful long-term survival is possible for selected patients suffering from advanced cancer of the abdomen when treated with cytoreductive surgery with Hyperthermic IntraPeritoneal Chemotherapy…

New data for engineering immune cells shows early promise in solid tumors

Engineered immune cells, called CARTmeso cells, designed to direct antitumor immune responses toward tumors that carry a protein called mesothelin, showed antitumor activity in two patients with…